At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Novel Treatment for Microvascular Erectile Dysfunction Combining Shockwave Therapy and Platelet Rich Plasma
In Brief
A Phase 1 clinical trial evaluating Shock Wave therapy (SWT), Platelet Rich Plasma (PRP), and 2 other interventions for Erectile Dysfunction. Completed, enrolled 59 participants across 1 site.
Detailed Summary
The purpose of this research study is to evaluate whether the combination of Shock Wave Therapy (SWT) with Platelet Rich Plasma (PRP) is synergistic and can reverse the pathology of microvascular Erectile Dysfunction (ED) and enhance erectile function by improving vasodilation, and endothelial function
Study Details
Timeline
Interventions
Each SWT will administer 720 shocks in the treatment arm. Total of 3600 shocks are given over 5 weeks treatment period.
5 mL PRP will be administered via intracavernous injection
Sham Shockwave Therapy will be administered in the sham arm.
5 mL Placebo saline will be administered via intracavernous injection in the sham arm.